Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled Trial
Crossref DOI link: https://doi.org/10.1007/s12325-020-01332-y
Published Online: 2020-04-18
Published Print: 2020-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Evans, Marc
Moes, Robert G. J.
Pedersen, Katrine S.
Gundgaard, Jens
Pieber, Thomas R.
Text and Data Mining valid from 2020-04-18
Version of Record valid from 2020-04-18
Article History
Received: 28 February 2020
First Online: 18 April 2020